switching from tirzepatide to semaglutide Switching Semaglutide to Tirzepatide |
Description
Some patients explore drug holidays or intermittent dosing strategies, though these require medical oversight and structured planning
Oellgaard J, Gde P, Rossing P, Persson F, Parving HH, Pedersen O
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered
The NHS Diabetes Prevention Programme, whilst designed for diabetes prevention, incorporates many principles applicable to general weight maintenance
Despite the catchy nickname, both experts agree that these changes are not exclusive to semaglutide medications
